8-K: Traeger Faces NYSE Delisting, Stockholders OK Reverse Split

Traeger, Inc. received a NYSE notice for failing to meet minimum share price requirements, prompting stockholder approval for a potential reverse stock split.

Summary

• Traeger, Inc. received a notice from the New York Stock Exchange (NYSE) on March 5, 2026, indicating non-compliance with Section 802.01C because its average closing price was less than $1.00 per share over a consecutive 30 trading-day period ended March 4, 2026.
• The notice does not result in immediate delisting; the company has a six-month cure period to regain compliance.
• To regain compliance, the company must achieve a closing price of at least $1.00 and an average closing share price of at least $1.00 over a 30 trading-day period by the end of the cure period.
• At a special meeting on March 2, 2026, stockholders approved a reverse stock split of the common stock at a ratio ranging from 1-for-10 to 1-for-50, with the final ratio to be determined by the Board of Directors.
• The NYSE notice does not affect the company's ongoing business operations, SEC reporting requirements, or trigger any violation of its debt obligations.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to the NYSE non-compliance, although the proactive shareholder approval for a reverse stock split offers a clear path to address the immediate listing issue.

Positives

• Stockholders proactively approved a reverse stock split (1-for-10 to 1-for-50) to address the minimum share price requirement, demonstrating a clear path to compliance.
• The NYSE notice does not result in immediate delisting, providing a six-month cure period for the company to regain compliance.
• The notice does not affect ongoing business operations, SEC reporting obligations, or trigger any violations of debt obligations.

Negatives

• The average closing price of common stock was less than $1.00 per share over a consecutive 30 trading-day period ended March 4, 2026, leading to a NYSE non-compliance notice.
• The company's stock price has fallen significantly enough to trigger delisting concerns, indicating poor market performance.

Risks

• Reactions from employees, vendors, customers, lenders, and investors to the NYSE notice of non-compliance.
• Ability to regain compliance with the minimum share price requirement within the applicable six-month cure period.
• Ability to comply with other NYSE listing standards and maintain the listing of common stock on the NYSE.
• Impact of management transitions on common stock.
• Ability to manage future growth effectively.
• Ability to expand into additional markets.
• Ability to maintain and strengthen the brand to generate and maintain ongoing demand for products.
• Ability to cost-effectively attract new customers and retain existing customers.
• Operating in a highly competitive market.
• Ability of stockholders to influence corporate matters.

Future Outlook

The company intends to remain listed on the NYSE and is evaluating available options to regain compliance, including a reverse stock split. The Board of Directors will determine whether and when to effect the reverse stock split and the specific ratio within the approved range. The company has a six-month cure period to regain compliance by achieving a closing price of at least $1.00 and an average closing price of at least $1.00 over a 30 trading-day period.

Management Comments

• "The Company intends to remain listed on the NYSE and is evaluating available options to regain compliance with the NYSE’s continued listing standards, including a reverse stock split."
• "The NYSE notice does not affect the Company’s ongoing business operations, reporting requirements with the Securities and Exchange Commission, nor does it trigger any violation of its debt obligations."

Industry Context

StockSavvy.ai notes that companies facing minimum price compliance issues often resort to reverse stock splits to maintain their listing, a common strategy to avoid the negative perception and liquidity challenges associated with delisting. This situation highlights the broader market's scrutiny on stock performance and the importance of maintaining exchange listing standards for investor confidence and access to capital markets.

Comparison to Industry Standards

• StockSavvy.ai observes that a stock price consistently below $1.00 is a significant underperformance compared to most established public companies listed on major exchanges like the NYSE.
• While reverse stock splits are a standard mechanism to address such issues, they do not fundamentally change a company's valuation or operational performance.
• The effectiveness of Traeger's move will depend on its ability to improve its core business and investor sentiment post-split, rather than just the cosmetic change in share price.

Stakeholder Impact

• Shareholders: Face potential dilution from a reverse stock split (in terms of fewer shares at a higher price, not percentage ownership), and uncertainty regarding the company's ability to maintain its NYSE listing.
• Employees: May experience uncertainty or morale impact due to the company's stock performance and delisting concerns.
• Investors: Will closely monitor the company's actions to regain compliance and the effectiveness of the reverse stock split.

Next Steps

• The Board of Directors will determine whether and when to effect the reverse stock split and the specific ratio (between 1-for-10 and 1-for-50).
• The company will continue to monitor the trading price of its common stock.
• The company will take actions necessary to regain compliance with NYSE continued listing standards within the six-month cure period.
• If the company determines to cure the deficiency by shareholder approval at its next annual meeting, the price condition will be deemed cured if the price promptly exceeds $1.00 per share and remains above that level for at least the next 30 trading days.

Key Dates

Recommendation

While the NYSE non-compliance is a significant negative, the company has a clear plan and shareholder approval for a reverse stock split to address the issue. The six-month cure period provides time for execution. Investors should hold to observe the effectiveness of the reverse split and any underlying business improvements, as the immediate delisting risk is mitigated by the cure period and planned action.

Keywords

Traeger, NYSE, Delisting, Reverse Stock Split, COOK, SEC Filing, Corporate Governance, Stock Price, Compliance, Shareholder Meeting